Home Digestive Disorders IBD: Crohn’s Disease What’s Health Canada Saying about Biosimilars?

IBD: Crohn's Disease

What’s Health Canada Saying about Biosimilars?

Tags: ,

 
A biosimilar biologic drug, or biosimilar, is a drug demonstrated to be highly similar to a biologic drug that was already authorized for sale (known as the reference biologic drug).  Biosimilars are approved based on a thorough comparison to a reference drug and may enter the market after the expiry of reference drug patents and data protection. Watch this video to get more insight into what Health Canada is saying about biosimilars!
 

This video was made possible by an unrestricted educational grant by Pfizer Canada. 

Related Articles

Life with Crohn’s Disease: Never give up

Tags: ,

*Important: This is an opinion piece. This information should not be used as a substitute for the medical care and advice of your physician. There may […]

Read More

Blackboards and Bathrooms – A comprehensive resource to help teachers support the education of children with IBD

Tags:

Blackboards and Bathrooms has been created especially for you – the educator. Inflammatory bowel disease (IBD) is an umbrella term for two disorders: Crohn’s disease and […]

Read More

CDHF Talks: Your New Infusion Clinic

Tags: ,

#CDHFTalks: Your New Infusion Clinic ‘Not the Same but Very Similar.’ Have you recently been diagnosed with Inflammatory Bowel Disease (IBD): Crohn’s disease or ulcerative colitis […]

Read More

What’s Health Canada Saying about Biosimilars?

https://www.youtube.com/embed/6DkzQFdyNuY
 
A biosimilar biologic drug, or biosimilar, is a drug demonstrated to be highly similar to a biologic drug that was already authorized for sale (known as the reference biologic drug).  Biosimilars are approved based on a thorough comparison to a reference drug and may enter the market after the expiry of reference drug patents and data protection. Watch this video to get more insight into what Health Canada is saying about biosimilars!